Loading...

Acute Metabolic Effects of Exenatide in Patients With Type 1 Diabetes With and Without Residual Insulin to Oral and Intravenous Glucose Challenges

OBJECTIVE: Glucagon-like peptide 1 (GLP-1) is an incretin hormone that is released from the gastrointestinal tract. Treatment with GLP-1 analogs has proven to be of clinical use for patients with type 2 diabetes. Patients with type 1 diabetes, particularly those with residual β-cell function, may al...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Ghazi, Tara, Rink, Linda, Sherr, Jennifer L., Herold, Kevan C.
Format: Artigo
Sprog:Inglês
Udgivet: American Diabetes Association 2014
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3968447/
https://ncbi.nlm.nih.gov/pubmed/23939544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-1169
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!